# Prophylaxis of Venous Thromboembolism in Advanced Lung Cancer

> **NCT01980849** · PHASE3 · UNKNOWN · sponsor: **Shengqing Li** · enrollment: 272 (estimated)

## Conditions studied

- Lung Cancer

## Interventions

- **DRUG:** Nadroparin, long term
- **DRUG:** Nadroparin: short-term

## Key facts

- **NCT ID:** NCT01980849
- **Lead sponsor:** Shengqing Li
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-11
- **Primary completion:** 2016-11
- **Final completion:** —
- **Target enrollment:** 272 (ESTIMATED)
- **Last updated:** 2013-11-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01980849

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01980849, "Prophylaxis of Venous Thromboembolism in Advanced Lung Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01980849. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*